• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An evaluation of subjective experiences, effects and overall satisfaction with clozapine treatment in a UK forensic service.一项关于英国法医服务中氯氮平治疗的主观体验、效果和总体满意度的评估。
Ther Adv Psychopharmacol. 2015 Jun;5(3):146-50. doi: 10.1177/2045125315581996.
2
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.针对对当前药物治疗反应不佳或不耐受的精神分裂症患者,开展传统抗精神病药物与新型非典型药物对比,以及新型非典型药物与氯氮平对比的随机对照试验。
Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165. doi: 10.3310/hta10170.
3
Subjective experiences of clozapine treatment by patients with chronic schizophrenia.慢性精神分裂症患者使用氯氮平治疗的主观体验
Psychiatr Serv. 2000 May;51(5):666-8. doi: 10.1176/appi.ps.51.5.666.
4
Patients' Experiences of Clozapine for Treatment-Resistant Schizophrenia: A Systematic Review.氯氮平治疗难治性精神分裂症患者的体验:一项系统评价
Schizophr Bull Open. 2022 Jul 10;3(1):sgac042. doi: 10.1093/schizbullopen/sgac042. eCollection 2022 Jan.
5
The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.专家共识指南系列。优化精神障碍的药物治疗。引言:方法、评论与总结。
J Clin Psychiatry. 2003;64 Suppl 12:5-19.
6
Patients' and primary carers' views on clozapine treatment for schizophrenia: A cross-sectional study in Qatar.患者及主要照顾者对氯氮平治疗精神分裂症的看法:卡塔尔的一项横断面研究。
Saudi Pharm J. 2023 Feb;31(2):214-221. doi: 10.1016/j.jsps.2022.12.005. Epub 2022 Dec 16.
7
Clozapine-induced hypersalivation: an estimate of prevalence, severity and impact on quality of life.氯氮平引起的唾液分泌过多:患病率、严重程度及对生活质量影响的评估
Ther Adv Psychopharmacol. 2016 Jun;6(3):178-84. doi: 10.1177/2045125316641019. Epub 2016 Mar 30.
8
Clozapine versus typical neuroleptic medication for schizophrenia.氯氮平与传统抗精神病药物治疗精神分裂症的比较。
Cochrane Database Syst Rev. 2000(2):CD000059. doi: 10.1002/14651858.CD000059.
9
The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.SOHO(精神分裂症门诊患者健康结局)研究:对精神分裂症治疗的启示
CNS Drugs. 2006;20(4):293-301. doi: 10.2165/00023210-200620040-00003.
10
The physical health and side-effect monitoring of patients prescribed clozapine: data from a clinical audit conducted in UK mental health services.使用氯氮平患者的身体健康及副作用监测:来自英国精神卫生服务机构临床审计的数据
Ther Adv Psychopharmacol. 2020 Aug 6;10:2045125320937908. doi: 10.1177/2045125320937908. eCollection 2020.

引用本文的文献

1
Oral Adverse Effects of Antipsychotic Medications: A Case/Noncase Analysis of EudraVigilance Data.抗精神病药物的口腔不良反应:基于欧洲药物警戒数据库数据的病例/非病例分析
Oral Dis. 2025 Aug;31(8):2630-2640. doi: 10.1111/odi.15337. Epub 2025 Apr 21.
2
The impacts of antipsychotic medications on eating-related outcomes: A mixed methods systematic review.抗精神病药物对饮食相关结果的影响:一项混合方法的系统评价。
PLoS One. 2025 Feb 3;20(2):e0308037. doi: 10.1371/journal.pone.0308037. eCollection 2025.
3
What is the current scope of research assessing patients' and clinicians' perspectives on clozapine treatment? A comprehensive scoping review.当前评估患者和临床医生对氯氮平治疗观点的研究范围是什么?一项全面的范围综述。
BMJ Open. 2025 Jan 15;15(1):e085956. doi: 10.1136/bmjopen-2024-085956.
4
Patients' Experiences of Clozapine for Treatment-Resistant Schizophrenia: A Systematic Review.氯氮平治疗难治性精神分裂症患者的体验:一项系统评价
Schizophr Bull Open. 2022 Jul 10;3(1):sgac042. doi: 10.1093/schizbullopen/sgac042. eCollection 2022 Jan.
5
Experience with and attitude toward clozapine use among patients receiving clozapine on long term and their caregivers.长期接受氯氮平治疗的患者及其照料者对使用氯氮平的体验和态度。
Indian J Psychiatry. 2023 Nov;65(11):1165-1175. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_585_23. Epub 2023 Nov 24.
6
Patients' and primary carers' views on clozapine treatment for schizophrenia: A cross-sectional study in Qatar.患者及主要照顾者对氯氮平治疗精神分裂症的看法:卡塔尔的一项横断面研究。
Saudi Pharm J. 2023 Feb;31(2):214-221. doi: 10.1016/j.jsps.2022.12.005. Epub 2022 Dec 16.
7
Eating cognitions, emotions and behaviour under treatment with second generation antipsychotics: A systematic review and meta-analysis.服用第二代抗精神病药物时的饮食认知、情绪和行为:系统评价和荟萃分析。
J Psychiatr Res. 2023 Apr;160:137-162. doi: 10.1016/j.jpsychires.2023.02.006. Epub 2023 Feb 8.
8
Differential Effects of Clozapine and Haloperidol on the 40 Hz Auditory Steady State Response-mediated Phase Resetting in the Prefrontal Cortex of the Female Sprague Dawley Rat.氯氮平和氟哌啶醇对雌性 Sprague Dawley 大鼠前额叶皮层 40 Hz 听觉稳态反应介导的相位重设的差异作用。
Schizophr Bull. 2023 May 3;49(3):581-591. doi: 10.1093/schbul/sbac203.
9
A Comparison of Attitudes, Comfort, and Knowledge of Clozapine Among Two Diverse Samples of US Psychiatrists.中美精神科医生对氯氮平的态度、舒适度和认知的比较。
Community Ment Health J. 2022 Apr;58(3):517-525. doi: 10.1007/s10597-021-00847-0. Epub 2021 May 29.
10
Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): a feasibility study.格隆溴铵与氢溴酸东莨菪碱及安慰剂治疗氯氮平引起的流涎过多的比较(GOTHIC1):一项可行性研究。
Pilot Feasibility Stud. 2019 Jun 17;5:79. doi: 10.1186/s40814-019-0462-1. eCollection 2019.

本文引用的文献

1
Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation.临床实践中治疗指南的遵循情况:氯氮平治疗前抗精神病药物治疗的研究。
Br J Psychiatry. 2012 Dec;201(6):481-5. doi: 10.1192/bjp.bp.111.105833. Epub 2012 Sep 6.
2
The Patient Assessment Questionnaire: initial validation of a measure of treatment effectiveness for patients with schizophrenia and schizoaffective disorder.患者评估问卷:用于评估精神分裂症和分裂情感性障碍患者治疗效果的测量工具的初步验证。
Psychiatry Res. 2012 Dec 30;200(2-3):857-66. doi: 10.1016/j.psychres.2012.06.006. Epub 2012 Jul 26.
3
Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection.停用氯氮平的原因:与长效利培酮注射剂进行匹配的病例对照比较。
Br J Psychiatry. 2009 Feb;194(2):165-7. doi: 10.1192/bjp.bp.108.051979.
4
Pharmacological interventions for clozapine-induced hypersalivation.氯氮平所致流涎的药物干预措施。
Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD005579. doi: 10.1002/14651858.CD005579.pub2.
5
Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.精神分裂症患者对抗精神病药物主观治疗满意度的评估
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):755-60. doi: 10.1016/j.pnpbp.2007.12.002. Epub 2007 Dec 14.
6
Side-effects and treatment with clozapine: a comparison between the views of consumers and their clinicians.氯氮平的副作用与治疗:消费者与临床医生观点之比较
Int J Ment Health Nurs. 2008 Feb;17(1):2-8. doi: 10.1111/j.1447-0349.2007.00506.x.
7
Patients' subjective experiences of antipsychotics: clinical relevance.患者对抗精神病药物的主观体验:临床相关性。
CNS Drugs. 2002;16(7):457-71. doi: 10.2165/00023210-200216070-00003.
8
Patients' and relatives' assessment of clozapine treatment.患者及家属对氯氮平治疗的评估。
Psychol Med. 2001 Apr;31(3):509-17. doi: 10.1017/s0033291701003749.
9
Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study.氯氮平治疗难治性精神分裂症、分裂情感性障碍和精神病性双相障碍:一项为期24个月的自然主义研究。
J Clin Psychiatry. 2000 May;61(5):329-34. doi: 10.4088/jcp.v61n0502.
10
Association of venous thromboembolism and clozapine.静脉血栓栓塞与氯氮平的关联
Lancet. 2000 Apr 1;355(9210):1155-6. doi: 10.1016/S0140-6736(00)02066-3.

一项关于英国法医服务中氯氮平治疗的主观体验、效果和总体满意度的评估。

An evaluation of subjective experiences, effects and overall satisfaction with clozapine treatment in a UK forensic service.

机构信息

Ashworth Hospital, Mersey Care NHS Trust, Liverpool, UK.

Ashworth Hospital, Mersey Care NHS Trust, Parkbourn, Liverpool, Merseyside L31 1HW, UK.

出版信息

Ther Adv Psychopharmacol. 2015 Jun;5(3):146-50. doi: 10.1177/2045125315581996.

DOI:10.1177/2045125315581996
PMID:26199716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4502588/
Abstract

OBJECTIVES

Patients prescribed clozapine were surveyed to assess (a) the effects, both positive and adverse, and overall satisfaction with clozapine in comparison to previously prescribed antipsychotics and (b) the relative significance of effects experienced, both positive and adverse, in terms of impact on subjective well-being.

METHODS

A total of 56 male patients prescribed clozapine at a forensic psychiatric hospital were surveyed using a 27-item questionnaire. All patients had been prescribed clozapine for a minimum of 3 months. Respondents were asked to rate effects and satisfaction with clozapine treatment in comparison with previously prescribed antipsychotic medication on a five-point scale. Respondents were also asked to rate effects experienced with clozapine treatment in terms of impact on subjective well-being on a five-point scale.

RESULTS

A total of 89% of respondents reported greater satisfaction with clozapine than with previously prescribed antipsychotic medication. A majority of patients reported positive effects in terms of an improvement in their quality of life (68%) and social abilities (52%) with clozapine in comparison with previously prescribed antipsychotics. Nocturnal hypersalivation (84%) and weight gain (57%) were the most common adverse effects. Hedonic responses were assessed for each effect in order to determine the associated subjective experiences. The most positive hedonic responses were for quality of life, mood and alertness. In terms of adverse impact on subjective well-being, nocturnal hypersalivation ranked highest.

CONCLUSIONS

Patients in a UK forensic sample are largely satisfied with clozapine treatment. The subjective effects of clozapine treatment should be taken into account by clinicians when assessing response. This may provide an opportunity to highlight the positive changes and prioritize management of the most undesirable adverse effects, which is likely to promote compliance and improve longer term treatment outcomes.

摘要

目的

调查服用氯氮平的患者,评估(a)与之前开的抗精神病药相比,氯氮平的积极和消极影响以及总体满意度,以及(b)积极和消极影响在多大程度上影响主观幸福感。

方法

对一家法医精神病院开氯氮平的 56 名男性患者进行了一项 27 项问卷调查。所有患者至少开氯氮平 3 个月。受访者被要求在五分制上对氯氮平治疗的效果和满意度与之前开的抗精神病药物进行评分。受访者还被要求在五分制上对氯氮平治疗的影响进行评分,以评估对主观幸福感的影响。

结果

89%的受访者表示,与之前开的抗精神病药物相比,他们对氯氮平更满意。大多数患者报告说,与之前开的抗精神病药物相比,他们的生活质量(68%)和社会能力(52%)有了改善,氯氮平有积极影响。夜间唾液分泌过多(84%)和体重增加(57%)是最常见的不良反应。为了确定相关的主观体验,对每种影响进行了享乐反应评估。对生活质量、情绪和警觉性的享乐反应最为积极。就对主观幸福感的不良影响而言,夜间唾液分泌过多排名最高。

结论

英国法医样本中的患者对氯氮平治疗基本满意。当评估反应时,临床医生应考虑氯氮平治疗的主观影响。这可能为突出积极变化并优先管理最不理想的不良反应提供机会,这可能会提高依从性并改善长期治疗结果。